CARRIERS OF M.3243A>G WHO RECEIVE TRANSPLANT MUST BE CLOSELY MONITORED FOR POSSIBLE MITOCHONDRIAL TOXICITY OF REQUIRED IMMUNOSUPPRESSANTS

JOSEF FİNSTERER

Experimental and Clinical Transplantation - 2025;23(8):569-570

Yazının özeti bulunmamaktadır